BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10858440)

  • 1. Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase.
    Blanchard F; Duplomb L; Wang Y; Robledo O; Kinzie E; Pitard V; Godard A; Jacques Y; Baumann H
    J Biol Chem; 2000 Sep; 275(37):28793-801. PubMed ID: 10858440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
    Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
    J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involving of the cytoplasmic region of leukemia inhibitory factor receptor alpha subunit, IL-6 related signal transducer-gp130 or fas death domain for MAPK p42/44 activation in HL-60 cell with LIF or anti-Fas IgG.
    Liu H; Dan J; Tang S; Wu S
    Mol Cell Biochem; 2001 Jan; 217(1-2):113-20. PubMed ID: 11269654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation.
    Schiemann WP; Graves LM; Baumann H; Morella KK; Gearing DP; Nielsen MD; Krebs EG; Nathanson NM
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5361-5. PubMed ID: 7777512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The box-1 region of the leukemia inhibitory factor receptor alpha-chain cytoplasmic domain is sufficient for hemopoietic cell proliferation and differentiation.
    Zhang Y; Willson T; Metcalf D; Cary D; Hilton DJ; Clark R; Nicola NA
    J Biol Chem; 1998 Dec; 273(51):34370-83. PubMed ID: 9852103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The carboxyl-terminal domains of gp130-related cytokine receptors are necessary for suppressing embryonic stem cell differentiation. Involvement of STAT3.
    Ernst M; Novak U; Nicholson SE; Layton JE; Dunn AR
    J Biol Chem; 1999 Apr; 274(14):9729-37. PubMed ID: 10092661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
    Hui W; Bell M; Carroll G
    Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct roles for leukemia inhibitory factor receptor alpha-chain and gp130 in cell type-specific signal transduction.
    Starr R; Novak U; Willson TA; Inglese M; Murphy V; Alexander WS; Metcalf D; Nicola NA; Hilton DJ; Ernst M
    J Biol Chem; 1997 Aug; 272(32):19982-6. PubMed ID: 9242667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
    Mosley B; De Imus C; Friend D; Boiani N; Thoma B; Park LS; Cosman D
    J Biol Chem; 1996 Dec; 271(51):32635-43. PubMed ID: 8999038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes.
    Thoma B; Bird TA; Friend DJ; Gearing DP; Dower SK
    J Biol Chem; 1994 Feb; 269(8):6215-22. PubMed ID: 8119965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
    FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6.
    Kuropatwinski KK; De Imus C; Gearing D; Baumann H; Mosley B
    J Biol Chem; 1997 Jun; 272(24):15135-44. PubMed ID: 9182534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms.
    Blanchard F; Wang Y; Kinzie E; Duplomb L; Godard A; Baumann H
    J Biol Chem; 2001 Dec; 276(50):47038-45. PubMed ID: 11602599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors.
    Boulton TG; Stahl N; Yancopoulos GD
    J Biol Chem; 1994 Apr; 269(15):11648-55. PubMed ID: 7512571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of leukemia inhibitory factor-stimulated neuronal gene expression by protein phosphatases SHP-1 and SHP-2 through mitogen-activated protein kinase-dependent and -independent pathways.
    Bartoe JL; Nathanson NM
    J Neurochem; 2000 May; 74(5):2021-32. PubMed ID: 10800945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
    J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade.
    Aubert J; Dessolin S; Belmonte N; Li M; McKenzie FR; Staccini L; Villageois P; Barhanin B; Vernallis A; Smith AG; Ailhaud G; Dani C
    J Biol Chem; 1999 Aug; 274(35):24965-72. PubMed ID: 10455174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M.
    Vernallis AB; Hudson KR; Heath JK
    J Biol Chem; 1997 Oct; 272(43):26947-52. PubMed ID: 9341130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling of type II oncostatin M receptor.
    Auguste P; Guillet C; Fourcin M; Olivier C; Veziers J; Pouplard-Barthelaix A; Gascan H
    J Biol Chem; 1997 Jun; 272(25):15760-4. PubMed ID: 9188471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.